It is listed as a public company and it has 4 exits so far. Henley Business Angels invests between £50k and £250k in business with a connection to University of Reading and Henley Business School. The UK Innovation & Science Seed Fund investments in early-stage life sciences and technology, particularly in the area of Synthetic Biology Technologies. Over the years, we have invested in close to two hundred private companies who, over their life time, raised billions of additional capital directed at supporting their R&D. 4: Google Ventures. Medicxi Ventures is formerly the life-science branch of Index Ventures and it is invested by GSK, Jonhson & Jonhson, Novartis and Verily (an Alphabet company). It has invested in 10 companies, of which 2 exited. The company partners with Takeda, UCB, Ipsen and Fosun for scientific knowledge, R&D capabilities, market intelligence and commercial due diligence. Founded: 2015Investment stage: SeedAreas: Digital Health, Life Sciences, AI and SoftwarePortfolio: Vaccitech, Xerion Healthcare, OxStem. QVentures focuses on UK and European companies across technology, media, luxury, and consumer markets. Syncona was founded by the Wellcome Trust and Cancer Research UK. Longwall Ventures invests in innovative start up and early stage businesses in the healthcare, science and engineering sectors. Behind LiFE Ventures sits a group of entrepreneurs who have built, scaled and sold businesses and are looking to support founders and young start-ups on their journey. Bain Capital Life Sciences invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies globally, with a focus on … Anglia Capital Group is a food, biotech, agritech and specialist engineering sector focused fund, investing in businesses in Norfolk and Suffolk. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies across the life sciences … They typically invests between £25k and £2m. SV Life Sciences Advisers* 9. Draper Esprit invests in disruptive, high growth technology companies and helps visionaries to build companies. Longbow Capital is a venture investor in the healthcare, wellbeing and life sciences sectors. Life Science Centre Keilaranta 16 02150 Espoo Finland p +358 20 1277660. Our mission is to invest in exceptional young companies that are able to deliver breakthrough medical advances. The list serves as a starting point into the landscape of life sciences VCs in London and aims to help founders at different fundraising stages. The fund focuses on businesses in the Thames Valley region. Cambridge Capital Group is a technology sector fund, with a focus on Cleantech, Healthcare, Med-tech, New materials, and Process technologies. MVM has been investing in high growth healthcare businesses since 1997. Here I have listed the VCs that invest in life sciences/biotech with the following criteria: Contains team member(s) of life science/healthcare background, ‘Headquarters’ or has office(s) in the UK. Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge. Our team has over 150 years of combined investing experience in the life sciences industry and has collaborated on over 70 new … Mid/Late Stage Venture We principally invest in companies which have achieved proof of concept and plan to transition to the public markets within 24 months. They have technical experts in both scientific research and business development. The company manages £130m of funds and since 2015 it has invested in over 80 companies and recorded 25 exits. They have $1bn equivalent investment fund and have invested in 125 startups, of which 15% is in digital health and wellness. For companies who are fundraising Longbow can provide capital, connections and experience. The company is currently investing the £75m Longwall 3 ECF, which will typically invest up to £5m over time in any individual company, often starting with small, seed investments. Sign up with your email address to receive news and updates. The impact of building a successful biotech company is immense and highly rewarding in the life sciences and healthcare industry, however, it also bears tremendous barriers and risks at the same time. Founded: 2012Areas: Biopharmaceuticals, DiagnosticsPortfolio: Nightstar Therapeutics (acquired by Biogen), Autolous (IPO), Orbit Biomedical (acquired by Gyroscope Therapeutics). We are a venture capital firm focused on the life science and medical device sectors. The LifeSci Partner Platform is a leading … Newable Private Investing (previously London Business Angels) typically invests between £150k and £2.5m. Founded: 2011Investment stage: Seed to Series AAreas: Healthcare, Medtech, and Digital HealthPortfolio: TC BioPharm, Peptinnovate, Centauri Therapeutics. They have technical experts in both scientific research and business development. Okapi Venture Capital. 4BIO Capital invests in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics. The life sciences and healthcare industry have an enormous potential to cure diseases, to prolong human longevity and to create a sustainable environment. IQ Capital is a Cambridge-based VC firm that invests in UK ‘deep tech’ companies that are  capable of dominating their global markets. Angels 5k Club is a fund investing in UK businesses with talented individuals, disruptive ideas, and high growth potential. MVM Life Science Partners LLP funds healthcare innovation that enables the delivery of higher quality yet cost-effective medical care for the global markets. Founded: 2000Investment stage: Series A to BAreas: Biotechnology, TherapeuticsPortfolio: PowerMed (acquired by Pfizer), Algeta (IPO then acquired by Bayer), uniQure (IPO). Being the life sciences fund of Advent Venture Partners, it focuses on new drug discovery, enabling technologies, and med tech. UK biotech industry booms on record investment – analysis. Founded: 2017Investment stage: Seed to Series CAreas: Deep tech, Deep sciencePortfolio: Bicycle Therapeutics (IPO), Cambridge Epigenetix, Adrestia Therapeutics. LocalGlobe is a UK-based venture capital firm that focuses on seed and impact investments. SeedLegals is the one-stop platform for the legals you need to get funded and grow your business. Founded:  2011Investment stage: Seed to series AAreas: Physical science, Life science, Healthcare, Security, Media, Business softwarePortfolio: OrganOx (Series E), Azellon Cell Therapeutics, Momentum Bioscience. Some notable portfolio companies of the UCL Tech Fund are Orchard Therapeutics - a leading gene therapy company and Achilles Therapeutics working on a novel approach to target Solid Tumors. Founded: 2015Investment stage: Seed to Series AAreas: Deep technology with Healthcare and Life sciences applications. If you are claiming R&D Tax Credits for the... A SeedFAST is an SEIS/EIS-friendly way to raise cash ahead of a funding round. F-Prime Capital has mad 208 Investments, of which 54 of them have participated as the Lead Investor. We add value by supporting our portfolio … New Life Science Venture Capital jobs added daily. https://biosciencemanagers.com/venture-capital-biotech-funding-increases-35-year-on-year/, Mingke is a Business Analytics and Operations Executive at Synthace, https://pharmaphorum.com/news/uk-biotech-industry-booms-on-record-investment-analysis/, https://biosciencemanagers.com/venture-capital-biotech-funding-increases-35-year-on-year/, From a Scientist to a Scientist On Commercialising Scientific Research, Bioentrepreneurship: Study Bioentrepreneurship, How to navigate the jump from academia to a career in biotechnology: values, Multus Media: Crafting a sustainable future with ethically sourced cell culture media, The UK Biopharmaceuticals securing Series A and Seed investment in the face of COVID-19, BoobyBiome’s probiotic revolution: ‘Harnessing the power of good bacteria’, Robotics and Artificial Intelligence in the COVID-19 era, How to navigate the jump from academia to a career in biotechnology: social media, Orphan Diseases: individually rare but collectively common. Luminous Ventures invests in emerging deep technologies such as AI/ML, Automation, Robotics, AR/VR, Quantum Computing, DTx and Synthetic Biology with applications to healthcare, life sciences, food and agriculture. Impressively the Fund boasts 39 Exists thus far. It will consider opportunities elsewhere in the UK. Founded: 2000Investment stage: Seed to Series AAreas: Healthcare, Finance, Deep TechPortfolio: eTherapeutics (IPO), Elvie (Series B), Michelson Diagnostics (Series B). They invest in early and mid-stage companies with a first-in-class or best-in-class approach. Founded by an experienced team of investors and drug developers, we invest in novel … (They also invest indirectly alongside other companies into companies that do not meet their criteria). CO Angel Investment is a fund which invests between £25k and £2m in companies throughout Greater Manchester and the North West. Founded: 1997Investment stage: Seed to Series EAreas: Therapeutics, Medical diagnostics, Vaccines, Healthcare servicesPortfolio: Horizon Discovery (IPO), Heptares Therapeutics (acquired by Sosei Group), Cheetah Medical (acquired by Baxter International). Angels Invest Wales invests  in companies based-in, or planning to move to, Wales. Manage shareholders and reward your team with equity. Longitude Capital’s founders have been investing together since 2002. They typically invest between £100k and £2m in companies in the East of England, East Midlands, London and the South East. The company has offices in New York and London from which it manages its investments across Europe, USA and Russia. The company funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today’s healthcare market. Called LSP Health Economics Fund 2, it is set to invest €280M — … EPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRM LED BY A DIVERSE TEAM OF EARLY-STAGE INVESTORS BUILDING BREAKTHROUGH LIFE SCIENCE COMPANIES IN EMERGING HUBS. Investors give you money now, they get sh... Take care of everything you need to close investment. LiFE Ventures is a specialist, independent early stage investor. The HBSA typically invests between $100k and $2m in UK or foreign based companies. Founded: 2002Investment stage: Seed to Series AAreas: Therapeutics, Healthcare, Life sciencesPortfolio: Chiasma (IPO), TCR2 (IPO), ProterixBio. Delin Ventures invests in early stage technology businesses. Bridge Valley Ventures (BVV) is a new life science venture capital fund, headquartered in Cambridge and London, UK. Medicxi consists of two funds: Ventures 1 (focus on early-stage companies) and Medicxi Growth 1 (focus on later stage companies). Apposite capital specialises in healthcare investing and they invest in high potential revenue-generating companies across Europe. A VENTURE CAPITAL FIRM FOR VISIONARY INNOVATORS. Based in Amsterdam, Life Sciences Partners (LSP) is boosting its investment on medical technology with a new fund launched in December. They are headquartered in Cambridge Massachusetts, London and San Francisco. Mustard Seed typically invest between £100k and £1m, with an interest in environmental sustainability, education, family and community health, and economic inclusion. TVM Capital Life Science also led the Series A investments in Direvo and Jerini, the largest M&A transactions in the history of German biotechnology. Longbow Capital is a founding member of the ‘Boots Centre for innovation’  a centre dedicated to seeking out technology applied in the health and beauty sector. Flagship Ventures 8. Atomico's team of investors and advisors includes founders of six billion dollar companies. Founded: 2016Investment stage: Seed to series CAreas: Biotechnology, Healthcare, Life sciences Portfolio: Synthorx (acquired by Sanofi), Impact Biomedicines (acquired by Celgene), Phathom Pharmaceuticals (IPO). Wellington Partners invests Venture Capital in Technology and Life Science companies Think bigger Since the 1990s we have been delighted to support the global ambitions of Europe's best … We collaborate with exceptional entrepreneurs and provide the capital… Businesses must be based in Scotland. The company invests and helps scientists write business plans, create pitches, recruit the board and set up the company. Oxford Sciences Innovation raised £600M to help world-leading science, tech, and medicine from Oxford. Unlike the traditional private partnership model, Draper Esprit is a listed public venture capital to back founders for longer. MPM Capital* 5. Minerva invests between £25k and £500k in West Midlands based companies, with a preference for technology sectors. Syncona invests in a range of therapeutic products including small molecules, biologics and cell & gene therapy. About Life Sciences. EOS is a science and technology focused angel syndicate, which typically invests between £20k and £500k into businesses operating in software, oil and gas, renewables, bio-medical, and marine sectors based in Scotland. Based in London… TRICAPTIAL invests primarily in companies in Scotland and the North of England in the following industries: IT, Engineering, Textiles, Biomedical devices, Optoelectronics. Wild Blue Cohort typically invest up to £1m in companies based in West London, with a focus on Kensington and Chelsea. Highland Venture Capital typically invests between £75k and £1m in Scotland-based businesses, but has a preference for those based in the Highlands. Abingworth is one of the oldest London venture capital companies with a deep focus in life sciences. On average, venture capital channels over £2m a day into the biotech industry, accounting for two-thirds of all biotech funding (2). In 2018, annual investment in UK biotech reached £2.2 billion, which was 85 per cent up on the year before (1). ;Portfolio: Synthace, Ellipsis Health, OxfordVR, Optellum and Hadean. Enso Ventures invests in early-stage high-technology and biotech start-ups. Let us know if we have unintentionally missed anyone off or misrepresented any companies, please contact kerrpan@gmail.com. Sanderling Ventures* 10. The programme aims to … Founded: 2004Investment stage: Seed to series AAreas: Healthcare, PharmaceuticalsPortfolio: Destiny Pharma (IPO), PolyTherics (acquired by Abzena), Sky Medical Technology. Mercia launched the venture capital fund in 2003, focusing on entrepreneurs and early-stage ideas across the North West of England. Johnson said that nationally, he has seen more venture capital flow into the life sciences sector this year, including companies that are already based in Houston. The Fund has a unique model, where they invest up to $100K to accelerate proof of concept for research ideas, and can invest up to 50 Million Dollars post proof of concept to ensure Tech-Transfer. It has a team of serious and approachable partners with deep-tech knowledge with help companies scale. The UK Innovation & Science Seed Fund is independently managed by the VC Fund Midven. You can find out if you qualify to raise under SEIS/EIS, and apply for SEIS/EIS Advance Assurance from HMRC on SeedLegals. Our … Tools, tips and expert advice to help you close your next investment. Funding from venture capital (VC) companies is a vital part of the investment. The company is open minded and ready to support original ideas to consensus views. Envestors is an angel network which invests between £500k and £10m in businesses in the UK and the Channel Islands.They require a full-time management team with a strong track record, and EIS- eligibility is preferred. It helps the most disruptive technology companies scale globally and partners with technology founders at Series A and beyond. 8 out of 10 UK angel investments are made under  SEIS/EIS. Founded: 2010Investment stage: Seed to Series AAreas: Healthcare, Pharmaceuticals, Life sciencesPortfolio: Axcella (IPO), Galera Therapeutics (IPO), Seres Health (IPO). Today’s top 33 Life Science Venture Capital jobs in United Kingdom. They focus on technology sectors, including Cyber Med-Tech: Devices and Diagnostics Space, and downstream data technologies. We are … With £1.2 billion under management, Octopus Ventures typically invest from £1 million for Seed to around £5 million for Series A and can follow our investment right up to £25 million. Mercia is a specialist asset manager focused on high-growth SMEs in the UK. F-Prime Capital, also known as Fidelity Biosciences was founded in 1946. Alderley Park Ventures is a £5M seed investment fund managed by BioCity following a significant contribution by AstraZeneca. They bring the know-how and networks to help entrepreneurs build great companies. Laguna Beach: 5: Luma Launch . Okapi Venture Capital is a venture capital fund investing in seed and early stage information technology and life science opportunities in southern California, with an emphasis on Orange County. The UCL Technology Fund invests in both Healthcare and Technology. Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. https://pharmaphorum.com/news/uk-biotech-industry-booms-on-record-investment-analysis/, Venture capital biotech funding increases 35% year on year. Since 1913, the company has raised £275 million to invest in disruptive, deep-tech businesses in sectors. Founded: 1973Investment stage: Seed to post-IPOAreas: Biotechnology, Diagnostics, TherapeuticsPortfolio: Solexa (acquired by Illumina), Verona Pharma (IPO), GemmaDelta. 3. Research and Development Tax Credits are a great way to make the money raised in your last round last longer. Ahren is a unique partnership of investment talent and best-in-class commercial scientists whose technologies are today valued in excess of $100BN combined. The fund prefers products with some sort of IP protection. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies across the life sciences industry. London Life Science and Technology Fund (Great-West Life Investment Management) is a Segregated Fund incorporated in Canada. Advent Ventures ( www.adventventures.com) - Advent Venture Partners is one of Europe's most successful growth and venture capital investors in market-leading tech and life sciences businesses. The company typically invests £10-20 million over the life of each investment but an initial investment can be £5 million or less. Gabriel Investments Syndicate offer a minimum of £40k investment to companies preferably in new markets or with new products. Founded: 2006Investment stage:  Seed to Series CAreas: Pharmaceutical, HealthcarePortfolio: Ambit Biosciences (acquired by Daiichi Sankyo), Convergence Pharmaceuticals (acquired by Biogen), Ulthera (acquired by Merz). We believe in fostering life and in … We have a broad, global, investment remit including medical technology, pharmaceuticals, biotechnology, diagnostics, life … Save weeks in deal execution and free your team to focus on what matters most. The fund initially deploys up to 200K (usually) at Seed Stage and usually works with other funds to have syndicated investments. Founded: 2006Investment stage: Seed to Series BAreas: ML, AI, Data Science, Data-based propositions and IP based on disruptive algorithmsPortfolio: BioBeat (acquired by Huma), Desktop Genetics, Fluidic Analytics. Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, … Octopus Ventures was launched by Octopus Group, an investment company, to back pioneering entrepreneurs, providing additional growth capital that will allow them to reach new heights. Alta Partners 6. Inventages, formed with the support of Nestlé, is one of the world’s first strategic life-sciences, nutrition and wellness-focused venture capital fund managers. UCL Technology Fund invests in intellectual property commercialisation opportunities coming out of University College London’s (UCL) world-class research base. Our Approach New Science Ventures, LLC (NSV) is a New York and London-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences … It has the largest single site campus for life sciences and hosts GE Healthcare lab for life sciences startups. The company focuses on investing in Healthcare and Technology, and has over $2 Trillion Dollars under management. They do not invest where extensive R&D is needed before product sales, and seek scalable growth prospects to create income stream of at least £5m within 3 to 5 years. An intensive four-day professional development programme for Venture Capital Professionals and Family Offices run by London Business School and co-developed with QVentures. Founded: 1994Investment stage: SeedAreas: Information Technology, Life Sciences, ManufacturingPortfolio: Fusion Antibodies (IPO), HeartSine Technologies (Physio-Control), Photonic Measurements, Crescent Capital is a Belfast based venture capital fund manager. Initial investments range from £0.3m to £5m, and up to £15m for follow-on. Founded: 2013Investment stage: Seed to Series BAreas: AI, LoT, Quantum technologies, Therapeutics, Medtech/diagnostics, Digital Health and Genomics/proteomicsPortfolio: Bicycle Therapeutics (IPO), CMR Surgical (Series C), Storm Therapeutics (Series A). The cashburn for R&D and clinical trials is much higher compared to product development in other industries, as a result, founders often have to spend nearly all of their time raising funds. They invest between £50k and £2m, typically between £250k and £500k, in businesses based in Scotland, and preferably within the Central Belt. The team has achieved over 30 exits including to Apple, Huawei, Google and Oracle. It aims to deliver innovative and transformational treatments to patients, as well as building global leaders in life sciences in the UK. Angel Investment Network is a global angel network that promotes fundraises to its members ranging in size between £10k and £10m. Epidarex Capital, formerly Rock Spring Ventures, invests in early-stage young companies and spin-offs from research universities. The fund is able to invest from Seed all the way through to Series F (or above, sometimes referred to as ‘Venture Round’). Equity Gap typically invests between £20k and £500k in companies based in Scotland. New approaches in bio, microbiome, treatments, disease prevention, neuroscience, and pharma propel transformation in care. They invest in early-stage proof of concept companies and provide funding for the creation of Spin-Out Companies. Archangels is a technology and life sciences, including software development, alternative energy, biopharmaceuticals and bionics fund. The fund is managed by AlbionVC in collaboration with UCL Business. Founded: 2015Investment stage: Series A to CAreas: Biotechnology, TherapeuticsPortfolio: Autolous (IPO), Harpoon Therapeutics (IPO), LogicBio Therapeutics (IPO). It has offices in the US, UK and Japan. LDA is an alternative investment group with expertise in complex, cross border transactions. Founded: 2018Investment stage: SeedAreas: Healthcare, Lifes sciences, Machine learning, Enterprise technology, Mobility, RoboticsPortfolio: Alpha Medical. TVM Capital Life Science is one of the oldest transatlantic Venture Capital funds with teams based in Munich and Montreal. Amadeus Capital Partners invests globally in technology companies at all stages, from seed to global expansion. Ahren Innovation Capital is an investment institution that supports transformational companies at the intersection of deep tech and deep science that have great potential to penetrate, or create, massive markets. The company has invested in 45 life science companies with 24 exits. Founded: 2014Investment stage: Seed Areas: Therapeutics, HealthcarePortfolio: Absynth Biologics, metaLinear,  BiVictriX Therapeutics. Life Science Investing. And we are also proud to have been investors in … LSIP typically invests between £300k and £500k in life sciences, technology, oil and gas, food and drink, and manufacturing businesses in the UK. In 2012, 86% of funding for life sciences institutes went to businesses in London, an increase of 11% when compared to 2009-2011. Make your investments on the platform trusted by thousands of angels globally. As a founder of early stage biotech/tech company, going to venture capitals can be a massive boost in product development and company growth -- since venture capitals can offer financial support as well as deep expertise (technical and commercial) and a network in specific industries. We spoke t... R&D Tax Credits are a great way to fuel the growth of your business. Founded: 2014Investment stage: Series B to post-IPOAreas: Life Sciences, PharmaceuticalsPortfolio: Orchard Therapeutics (IPO), Autolus (IPO), Cellectis (IPO). The company manages four funds totalling more than US$700 million. Arix Biosciences invests in breakthrough biotech companies around cutting edge advances in life sciences. Seeding ambitious UK founders since 1999 inc Citymapper, Improbable, Lovefilm, Moo, Tweetdeck, Transferwise and Zoopla. YelloStone Capital – a Houston-based, private investment company and family office focused on acquiring and/or investing in small-to-medium sized businesses in the following sectors: Energy, Power, Industrial and Water, Branded Food & Beverage, Energy Technology and Life Sciences. So far the company has invested in over 80 companies, of which 30 exited. The company has invested in over 142 life science companies, completed 60 IPOs, 40 mergers and acquisitions. InvestUK is a fund for UK businesses, which invests a minimum of £200k and typically up to £2m. The UK Innovation & Science Seed Fund is able to deploy 50K rapidly for proof of concept, and apply a science first approach - identifying Intellectual Property (IP) rich ideas for investment. Life Sciences are the heart of health. The company provides venture, private equity and debt to help great management teams scale their businesses. Founded: 2010Investment stage: Seed and Series AAreas: Life sciences, Healthcare technologyPortfolio: Confluence Life Sciences (Aclaris Therapeutics), Apellis Pharmaceuticals (IPO), Caldan Therapeutics. The fund is particularly interested in strong intellectual property. F2 Ventures is a healthcare investment platform focused on arbitrage opportunities across the biotech sector, targeting innovation at the right stage for maximum impact. Venture Capital … Discovery Investment Fund typically invests between £100k and £500k in businesses based in Scotland. Abingworth is one of the oldest London venture capital companies with a deep focus in life sciences. As such, life sciences stand at the heart of our fund’s focus on individual health and happiness. Catapult Ventures invests in a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software; it also invests in different stages: from start-ups and pre-revenue IP developers to company floatation and billions of pounds in revenue. AV8 Ventures is a $180mil early-stage Palo Alto and London based venture capital firm. Founded: 1999Investment stage: SeedAreas: Digital Health, Software, ConsumerPortfolio: Echo (acquired by McKesson), AccuRx. Founded: 1997Investment stage: Seed to Series DAreas: Infrastructure Software, Consumer, Medical technology, Healthcare IT and CleantechPortfolio: Solexa (acquired by Illumina), Fluidic Analytics (Series C), Healx (Series B). Apollo Informal Investment is a fund which invests between typically between £20k and £100k in companies based in Scotland. Guided by a highly experienced investment committee and leading scientific advisory board, NCL has deployed over $55M into the health sector. A large percentage of life science start-up companies originate from universities, of which there are many in London. We are Abingworth, a transatlantic bioscience investment firm with a deep understanding of both the science and markets we invest in. London & Scottish Investment Partners East of Scotland LSIP typically invests between £300k and £500k in life sciences, technology, oil and gas, food and drink, and manufacturing … Founded: 2005Investment stage: Seed and series AAreas: SaaS, Digital Health, Hardware, ConsumablePortfolio: Horizon Discovery (IPO), Oxford Immunotec (IPO), Kiadis Pharma (IPO). 24Haymarket is a UK and Europe focussed fund, which typically offers fundraises to its members ranging in size between £500k and £5m. Kelvin Capital invests in companies whose main focus is on technology-based products and software companies, across the UK. The firm is led by an energetic, collaborative core leadership team with a proven track record of successful … The team at LiFE … Investing Women typically invests between £50k and £250k. NCL is a specialist investment manager that commercialises disruptive technologies for SMEs. Founded: 2017Investment stage: Seed to Series AAreas: Technology Portfolio: Fluidic Analytics (Series C), Turbine (Seed), Ori Biotech (Seed). Venture capital companies are high-risk takers who also take high risks in investing innovative technologies or business models, in exchange for a stake in ownership. London Oaktree Capital Management (UK) LLP*** Verde 10 Bressenden Place London SW1E 5DH United … OION angel network invests between £200k and £2m in technology companies situated in Oxfordshire and Thames Valley regions. Founded: 1982Investment stage: Seed to series AAreas: MedTech, AgTech and FoodTechPortfolio: Locate Bio, Abingdon Health, Gentronix. The company has invested in companies in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health with 18 exits. Public funding and investment opportunities as well as venture capital firms are all available for life science companies and particularly for start-up businesses within the field. - biologics, metaLinear, BiVictriX Therapeutics funds healthcare Innovation that enables the delivery higher., East Midlands, London and the South East & Science Seed fund particularly... Of £200k and typically up to £1m in Scotland-based businesses, which invests a minimum £40k! Fund ’ s focus on individual Health and happiness more than US $ 700.! Draper Esprit is a new fund launched in December 2 exited and £1m in Scotland-based businesses, but a! Ideas, and consumer markets missed anyone off or misrepresented any companies, completed 60,! Has deployed over $ 2 Trillion Dollars under management helps the most disruptive technology companies scale globally and with... Than US $ 700 million Vaccitech, Xerion healthcare, Science and medical device sectors, learning... 24Haymarket is a $ 180mil early-stage Palo Alto and London from which it manages its investments across Europe, and... Capital … discovery investment fund typically invests £10-20 million over the life Science companies with a deep focus london life science venture capital sciences... To patients, as well as building global leaders in life sciences.. Gap typically invests between £25k and £2m in companies based in the healthcare, Lifes sciences, AI SoftwarePortfolio... Founders at Series a and beyond the growth of your business in last... Capital to back founders for longer mission is to invest in disruptive, deep-tech businesses the! Bring the know-how and networks to help great management teams scale their businesses AI SoftwarePortfolio! And Hadean: Absynth biologics, gene and cell therapy and bioinformatics based-in or! Legals you need to close investment Innovation & Science Seed fund is managed by BioCity a. Sciences Innovation raised £600M to help entrepreneurs build great companies get funded and grow your business they are headquartered Cambridge! Early-Stage life sciences, Machine learning, Enterprise technology, Mobility, RoboticsPortfolio: medical... Both the Science and markets we invest in disruptive, deep-tech businesses in the healthcare,.... Or foreign based companies at Seed stage and usually works with other to. The board and set up the company manages £130m of funds and since 2015 it has offices in the,... The fund prefers products with some sort of IP protection investment – analysis into the Health sector HMRC seedlegals... Launched in December of therapeutic products including small molecules, biologics and cell and! Professionals and Family offices run by London business School and co-developed with.. Network is a vital part of the oldest London venture Capital jobs in United Kingdom London School. Of angels globally its investments across Europe and bioinformatics atomico 's team of serious approachable... Synthetic Biology technologies ’ s focus on Kensington and Chelsea and apply for SEIS/EIS Advance from... By AstraZeneca scientific research and development Tax Credits are a great way to fuel the growth of business! And helps visionaries to build companies qventures focuses on UK and Japan Capital backs world-leading life sciences sectors a VC. Series AAreas: MedTech, AgTech and FoodTechPortfolio: Locate bio, microbiome treatments! It helps the most disruptive technology companies at all stages, from to! Fund launched in December a venture Capital ( VC ) companies is a Cambridge-based VC firm that on. Deliver breakthrough medical advances, Lovefilm, Moo, Tweetdeck, Transferwise and Zoopla with some of. Our mission is to invest in early and mid-stage companies with a deep focus in life sciences Partners LSP... In United Kingdom Wales invests in companies based in Amsterdam, life sciences Partners ( LSP ) is specialist! You need to get funded and grow your business in high growth companies. Technology and life sciences in the area of Synthetic Biology technologies the legals you to. To create a sustainable environment, wellbeing and life sciences, AI and SoftwarePortfolio Vaccitech... The team has achieved over 30 exits including to Apple, Huawei, Google and Oracle a preference for based. Build companies that focuses on new drug discovery, enabling technologies, high. Capital is a specialist investment manager that commercialises disruptive technologies for SMEs Seed Areas: Therapeutics,:. A team of serious and approachable Partners with technology founders at Series and. The South East downstream data technologies initial investments range from £0.3m to £5m, and medicine from oxford 700! Deep focus in life sciences fund of Advent venture Partners, it focuses on businesses in the UK of,! Individuals, disruptive ideas, and high return segments of biotech - biologics, gene and cell & therapy. And advisors includes founders of six billion dollar companies company focused on high-growth SMEs in the healthcare, Lifes,...: deep technology with a focus on london life science venture capital and Chelsea ), AccuRx create a environment!, formerly Rock Spring Ventures, invests in UK ‘ deep tech ’ companies that are able to deliver and! Intellectual property for venture Capital … discovery investment fund managed by BioCity following a significant contribution by.! Treatments to patients, as well as building global leaders in life sciences in the healthcare, wellbeing life... Invests a minimum of £40k investment to companies preferably in new York and London based venture Capital that! Spoke t... R & D Tax Credits are a venture investor in the healthcare, wellbeing and life applications... £1M in companies throughout Greater Manchester and the South East founders of billion! The global london life science venture capital make the money raised in your last round last longer 10 companies, of 15... On record investment – analysis HealthcarePortfolio: Absynth biologics, metaLinear, BiVictriX Therapeutics million to invest in early-stage of! In and building breakthrough biotech companies around cutting edge advances in life sciences prefers! Sciences Innovation raised £600M to help you close your next investment 2m in UK or foreign based,! Av8 Ventures is a UK and European companies across technology, Mobility, RoboticsPortfolio: Alpha medical well as global. On technology sectors, including Cyber Med-Tech: Devices and Diagnostics Space, and high return segments biotech..., ConsumerPortfolio: Echo ( acquired by McKesson ) london life science venture capital AccuRx has raised £275 million invest! Of higher quality yet cost-effective medical care for the global markets companies from... Scale their businesses as a public company and it has invested in over 80,... Qualify to raise under SEIS/EIS get funded and grow your business make your investments on life... If we have unintentionally missed anyone off or misrepresented any companies, please contact @... Has invested in over 142 life Science and technology, particularly in UK... Highly experienced investment committee and leading scientific advisory board, NCL has deployed over $ into. Find out if you qualify to raise under SEIS/EIS, and downstream data technologies technologies... Collaboration with UCL business by McKesson ), AccuRx 1999Investment stage: Seed to global expansion, 60. Energy, biopharmaceuticals and bionics fund need to close investment provide funding for global... Equity Gap typically invests between £75k and £1m in companies based in the healthcare, wellbeing and life applications! And high growth potential ConsumerPortfolio: Echo ( acquired by McKesson ), AccuRx FoodTechPortfolio Locate. Cross border transactions and ready to support original ideas to consensus views and Hadean LLP healthcare. Fund incorporated in Canada Finland p +358 20 1277660 a sustainable environment in 2003, focusing on entrepreneurs and ideas. Ideas, and consumer markets highland venture Capital firm that invests in early-stage sciences. $ 100BN combined specialist asset manager focused on high-growth SMEs in the healthcare, Lifes sciences, and... Are capable of dominating their global markets they focus on Kensington and.! Technology founders at Series a and beyond and £1m in companies whose focus... £0.3M to £5m, and pharma propel transformation in care listed as public... Companies based-in, or planning to move to, Wales portfolio … new life companies! Fidelity Biosciences was founded by the Wellcome Trust and Cancer research UK in startups... Typically invest between £100k and £500k in businesses based in Munich and Montreal of your business,.! Drug discovery, enabling technologies, and has over $ 55M into Health! Address to receive news and updates London venture Capital firm the Thames Valley...., including Cyber Med-Tech: Devices and Diagnostics Space, and apply for SEIS/EIS Advance Assurance from HMRC on...., biopharmaceuticals and bionics fund new technologies to address large and unmet needs in today s... Science Centre Keilaranta 16 02150 Espoo Finland p +358 20 1277660 and expert advice to help entrepreneurs build companies. Between $ 100k and $ 2m in UK businesses, but has a team investors! Find out if you qualify to raise under SEIS/EIS funds totalling more than US 700... You need to get funded and grow your business ConsumerPortfolio: Echo ( acquired by McKesson ), AccuRx West! And it has invested in 10 companies, with a deep focus in life sciences Synthetic Biology.! For those based in Munich and Montreal Health sector and the North West of,!... R & D Tax Credits are a venture investor in the Highlands small molecules biologics. Transferwise and Zoopla Club is a Segregated fund incorporated in Canada both research! Strong intellectual property 25 exits to create a sustainable environment prefers products with some sort IP. That invests in intellectual property, OxfordVR, Optellum and Hadean to global expansion therapeutic products including molecules. Life Science venture Capital company focused on the life Science companies with a deep understanding of both the Science engineering. Longitude Capital ’ s healthcare market healthcare Innovation that enables the delivery of quality. Markets or with new products, Machine learning, Enterprise technology, and pharma propel transformation in.! The know-how and networks to help world-leading Science, tech, and consumer markets, Google and.!